Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06265506 · ClinicalTrials.gov registry record · NA

Virtual Incentive Treatment for Alcohol

A NA study of Alcohol Use Disorder and Alcohol Drinking, sponsored by Washington State University.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06265506: Recruiting NA study of Alcohol Use Disorder and Alcohol Drinking, sponsored by Washington State University.

NCT06265506 is a NA study of Alcohol Use Disorder and Alcohol Drinking that is actively recruiting participants, run by Washington State University. The registered enrollment target is 200 participants, below the 327-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06265506, a NA study of Alcohol Use Disorder and Alcohol Drinking, is actively recruiting participants, sponsored by Washington State University.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this program of research is to utilize phosphatidylethanol (PEth), a blood-based biomarker that can detect alcohol use for up to 28 days to deliver a feasible telehealth-based 26-week CM intervention. This study will test a telehealth PEth-based CM model in a sample of adults with AUD (n=200), recruited via online platforms by randomizing individuals to six months of 1) an online cognitive behavioral therapy for AUD (CBT4CBT) and telehealth PEth-based CM (CM condition) or 2) CBT4CBT and reinforcers for submitting blood samples (no abstinence required) (control condition). Investigators will assess group differences in PEth-defined abstinence and regular excessive drinking (PEth \>= 200 ng/mL), and alcohol-related harms (e.g., smoking, drug use). This study will address important gaps in CM research by assessing outcomes during a 12-month follow-up, which is much longer than most previous CM studies; using a conceptual model to identify predictors of post-treatment abstinence. Investigators will conduct an economic analysis to place the cost of this model in the context of downstream CM-associated cost-offsets and improvements in personal and public health.

Primary Outcome

Investigators will use PEth 16:0/18:1, detectable from 8 to 5,000+ ng/mL via HPLC/MS/MS to assess the primary outcome. Abstinence from alcohol, the primary outcome, will be defined as a week-over-week PEth 16:0/18:1 reduction in Initiation Phase and PEth 16:0/18:1 \< 20 ng/mL in Maintenance Phase. The primary Aim 3 outcome will be PEth-defined abstinence (PEth 16:0/18:1 \< 20 ng/mL) during the 12-month follow-up.

Conditions Studied

Alcohol Use Disorder Alcohol Drinking Alcohol Abuse Alcohol Dependence

Interventions

  • BEHAVIORAL Contingency Management
  • BEHAVIORAL Computer Based Training for Cognitive Behavioral Therapy for AUD (CBT4CBT)

Study Locations (1)

Washington

  • Washington State University - Spokane

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-06-18
Est. Completion 2028-04-04
Phase NA
Washington State University

64 total trials

What NCT06265506 shows while recruiting

NCT06265506 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 327-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (39% lower).

The record links to 4 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Contingency Management is the first listed.

NCT06265506 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT06265506 about?

NCT06265506 is a clinical study titled "Virtual Incentive Treatment for Alcohol". The overall objective of this program of research is to utilize phosphatidylethanol (PEth), a blood-based biomarker that can detect alcohol use for up to 28 days to deliver a feasible telehealth-based 26-week CM intervention. This study will test a telehealth PEth-based CM model in a sample of adult...

What is the current status of trial NCT06265506?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-06-18. Estimated completion is 2028-04-04.

What conditions does trial NCT06265506 study?

This clinical trial studies the following conditions: Alcohol Use Disorder, Alcohol Drinking, Alcohol Abuse, Alcohol Dependence.

What interventions are being tested in trial NCT06265506?

The interventions under investigation include: Contingency Management (BEHAVIORAL), Computer Based Training for Cognitive Behavioral Therapy for AUD (CBT4CBT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06265506?

This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06265506 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06265506's enrollment target sits among peer trials

200 43rd of 184 higher than 137 of 184 other Alcohol Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06265506

Source: ClinicalTrials.gov NCT06265506, the US trial registry maintained by the National Library of Medicine. NCT06265506 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.